Quantcast
Last updated on April 20, 2014 at 8:28 EDT

Latest Greg Heinlein Stories

2013-11-14 08:24:59

HOUSTON, Nov. 14, 2013 /PRNewswire/ -- ION Geophysical Corporation (NYSE: IO) today announced that Greg Heinlein, ION's Senior Vice President and Chief Financial Officer, will be presenting at the Barclays Select Growth Conference to be held in New York City on November 18 - 19, 2013. Mr. Heinlein is scheduled to present on Tuesday, November 19, 2013 at 3:35 p.m. Eastern Time. The accompanying slides will be available that day in the Investor Relations section of the ION website at...

2013-10-01 16:22:28

HOUSTON, Oct. 1, 2013 /PRNewswire/ -- ION Geophysical Corporation (NYSE: IO) today announced that Greg Heinlein, ION's Senior Vice President and Chief Financial Officer, will be presenting at the Westlake Securities New Frontiers in Energy Conference to be held in Austin, Texas on October 7 - 8, 2013. Mr. Heinlein is scheduled to present on Tuesday, October 8, 2013 at 11:05 a.m. Central Time. The accompanying slides will be available that day in the Investor Relations section of the...

2013-09-26 08:22:30

HOUSTON, Sept. 26, 2013 /PRNewswire/ -- ION Geophysical Corporation (NYSE: IO) today announced that Greg Heinlein, ION's Senior Vice President and Chief Financial Officer, will be presenting at the Johnson Rice Energy Conference to be held in New Orleans, Louisiana on September 30 - October 2, 2013. Mr. Heinlein is scheduled to present on Wednesday, October 2, 2013 at 1:05 p.m. Central Time. The accompanying slides will be available that day in the Investor Relations section of the...

2013-09-05 16:22:24

HOUSTON, Sept. 5, 2013 /PRNewswire/ -- ION Geophysical Corporation (NYSE: IO) today announced that Brian Hanson, ION's President and Chief Executive Officer, and Greg Heinlein, Senior Vice President and Chief Financial Officer, will be attending the Barclays CEO Energy-Power Conference to be held in New York City on September 11 to 13, 2013. Brian Hanson is scheduled to present on Friday, September 13, 2013 at 9:45 a.m. Eastern Time. A live broadcast of the presentation with the...

2013-09-03 16:24:07

HOUSTON, Sept. 3, 2013 /PRNewswire/ -- ION Geophysical Corporation (NYSE: IO) today announced that Greg Heinlein, ION's Senior Vice President and Chief Financial Officer, will be presenting at the Pareto Securities 20(th) Oil & Offshore Conference to be held in Oslo, Norway on September 4 & 5, 2013. Mr. Heinlein is scheduled to present on Wednesday, September 4, 2013 at 9:00 a.m. Eastern Time (3:00 p.m. Oslo Time). The accompanying slides will be available in the Investor...

2012-11-26 16:22:42

HOUSTON, Nov. 26, 2012 /PRNewswire/ -- ION Geophysical Corporation (NYSE: IO) today announced that Greg Heinlein, ION's Senior Vice President and Chief Financial Officer, will be presenting at the Dahlman Rose & Co. Ultimate Oil Services and E&P Conference to be held in New York City on December 3 - 4, 2012. Mr. Heinlein is scheduled to present on Tuesday, December 4, 2012 at 1:45 p.m. Eastern Time. The accompanying slides will be available in the Investor Relations section of the...

2012-09-11 10:22:49

HOUSTON, Sept. 11, 2012 /PRNewswire/ -- ION Geophysical Corporation (NYSE: IO) today announced that Greg Heinlein, ION's Senior Vice President and Chief Financial Officer, will be presenting at the Pareto Securities Oil & Offshore Conference to be held in Oslo, Norway on September 12 - 13, 2012. Mr. Heinlein is scheduled to present on September 12 at 5:45 PM GMT (Oslo standard time). A copy of the slide presentation will be available in the Investor Relations section of...

2011-09-06 06:00:00

AUSTIN, Texas, Sept. 6, 2011 /PRNewswire/ -- Genprex, Inc., formerly known as Convergen LifeSciences, Inc., announced today that its first product candidate, the nanomolecular cancer therapy CNVN202, will be branded as Oncoprex(TM). "We are establishing the Oncoprex brand in the oncology sector in recognition of our advancing development programs. We anticipate that when approved, Oncoprex will be used to unlock the unrealized potential of a growing list of cancer therapies that have...